Rebecca Goldfaden

Chief Scientific Officer And Head Of Business Development at Rovia Clinical Research

Rebecca Goldfaden has extensive experience in the clinical research and pharmaceutical sectors, serving in various leadership roles. At Rovia Clinical Research from October 2023 to April 2025, Rebecca held titles including Chief Scientific Officer, Head of Business Development, and Head of Scientific Affairs, as well as Chief Operating Officer. Prior to this, Rebecca was the Chief Operating Officer, Vice President of Clinical Operations, and Director of Clinical Operations at East Coast Institute For Research from July 2014 to April 2024. Earlier career experiences include a role as Scientific Manager at ECIR Medical Communications and positions at Walmart as a Pharmacist, Pharmacy Intern, and Pharmacy Technician. Additionally, Rebecca completed a PGY-1 Pharmacy Residency at James A. Haley Veterans' Hospital. Educationally, Rebecca earned a Doctor of Pharmacy (Pharm.D.) degree from the University of Florida between January 2007 and December 2011.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Rovia Clinical Research

Innovative medicines, cures, and products stem from innovative research initiatives. That’s where Rovia comes in. Study to study, phase to phase, patient to patient… Rovia stands at the cutting edge of clinical research. Founded in 2007 on the principles of exceptional patient care and scientific collaboration, the company is comprised of highly experienced professionals from diverse backgrounds and disciplines, including physicians, scientists, nurses, bio-pharma and therapeutic specialists certified in clinical research. This unique combination has proven to be vital to the successful design, implementation and completion of our complex clinical studies. So too has been our ability to work collaboratively with our sponsors, CROs and investigators to ensure that our studies provide unerringly precise results, supported by careful data collection and comprehensive analysis. Our efficient start-up, enrollment, and retention processes also facilitate consistent, open communication with our full research team. Located in communities throughout the southeastern U.S., our clinical research sites include those fully owned by Rovia as well as a number operated in partnership with independent medical providers. In the latter instances, Rovia specialists manage and provide complete research support on site. This novel hybrid site model has helped accelerate and advance trial site selection and activation as well as access to diverse, underserved communities. Improved patient care, research predictability, efficiency and successful outcomes are further byproducts.